LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Dasatinib | 1.11 | uM | LJP5 | 72 | hr | 929 | 1283 | 3237 | 0.3964 | 0.1963 |
Hs 578T | Dasatinib | 1.11 | uM | LJP6 | 72 | hr | 929 | 1201 | 3216 | 0.3736 | 0.1543 |
Hs 578T | Dasatinib | 3.33 | uM | LJP5 | 72 | hr | 929 | 1290 | 3237 | 0.3987 | 0.1992 |
Hs 578T | Dasatinib | 3.33 | uM | LJP6 | 72 | hr | 929 | 1040 | 3216 | 0.3235 | 0.0652 |
Hs 578T | Dasatinib | 10 | uM | LJP5 | 72 | hr | 929 | 1142 | 3237 | 0.3529 | 0.1213 |
Hs 578T | Dasatinib | 10 | uM | LJP6 | 72 | hr | 929 | 825 | 3216 | 0.2564 | -0.0645 |
Hs 578T | Tozasertib | 0.04 | uM | LJP5 | 72 | hr | 929 | 1399 | 3237 | 0.4321 | 0.2549 |
Hs 578T | Tozasertib | 0.12 | uM | LJP5 | 72 | hr | 929 | 1299 | 3237 | 0.4015 | 0.2045 |
Hs 578T | Tozasertib | 0.37 | uM | LJP5 | 72 | hr | 929 | 1386 | 3237 | 0.4282 | 0.2486 |
Hs 578T | Tozasertib | 1.11 | uM | LJP5 | 72 | hr | 929 | 1283 | 3237 | 0.3963 | 0.1962 |
Hs 578T | Tozasertib | 3.33 | uM | LJP5 | 72 | hr | 929 | 1367 | 3237 | 0.4224 | 0.2387 |
Hs 578T | Tozasertib | 10 | uM | LJP5 | 72 | hr | 929 | 1127 | 3237 | 0.3484 | 0.1134 |
Hs 578T | Imatinib | 0.04 | uM | LJP6 | 72 | hr | 929 | 3231 | 3216 | 1.0043 | 1.0047 |
Hs 578T | Imatinib | 0.12 | uM | LJP6 | 72 | hr | 929 | 3189 | 3216 | 0.9913 | 0.9900 |
Hs 578T | Imatinib | 0.37 | uM | LJP6 | 72 | hr | 929 | 3333 | 3216 | 1.0361 | 1.0400 |
Hs 578T | Imatinib | 1.11 | uM | LJP6 | 72 | hr | 929 | 3363 | 3216 | 1.0455 | 1.0501 |
Hs 578T | Imatinib | 3.33 | uM | LJP6 | 72 | hr | 929 | 3546 | 3216 | 1.1025 | 1.1120 |
Hs 578T | Imatinib | 10 | uM | LJP6 | 72 | hr | 929 | 3625 | 3216 | 1.1269 | 1.1377 |
Hs 578T | NVP-TAE684 | 0.04 | uM | LJP6 | 72 | hr | 929 | 2877 | 3216 | 0.8946 | 0.8795 |
Hs 578T | NVP-TAE684 | 0.12 | uM | LJP6 | 72 | hr | 929 | 2015 | 3216 | 0.6265 | 0.5403 |
Hs 578T | NVP-TAE684 | 0.37 | uM | LJP6 | 72 | hr | 929 | 2237 | 3216 | 0.6955 | 0.6326 |
Hs 578T | NVP-TAE684 | 1.11 | uM | LJP6 | 72 | hr | 929 | 1773 | 3216 | 0.5514 | 0.4344 |
Hs 578T | NVP-TAE684 | 3.33 | uM | LJP6 | 72 | hr | 929 | 1207 | 3216 | 0.3753 | 0.1572 |
Hs 578T | NVP-TAE684 | 10 | uM | LJP6 | 72 | hr | 929 | 815 | 3216 | 0.2534 | -0.0707 |
Hs 578T | CGP60474 | 0.04 | uM | LJP5 | 72 | hr | 929 | 3045 | 3237 | 0.9404 | 0.9328 |